0.84 USD
↗ 0.10 (13.19%)AT CLOSE (11:59 AM EDT)
Estrella Immunopharma, Inc. Common Stock
ESLANASDAQ • USD
0.85
↗ 0.01 (1.55%)
POST MARKET (AS OF 05:30 PM EDT)
Post Market
AS OF 05:30 PM EDT
0.85
↗ 0.01 (1.55%)
Market: OPEN
ESLA is currently priced at $0.77. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (251.4%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Jul 17, 2026.
Open?$0.80
High?$0.94
Low?$0.77
Prev. Close?$0.74
Volume?252.8K
Avg. Volume?43.7K
VWAP?$0.86
Rel. Volume?5.79x
Bid / Ask
Bid?$0.70 × 100
Ask?$1.02 × 100
Spread?$0.32
Midpoint?$0.86
Valuation & Ratios
Market Cap?31.8M
Shares Out?43.0M
Float?15.1M
Float %?35.2%
P/E Ratio?N/A
P/B Ratio?-6.04
EPS?-$0.31
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Employees
N/A
Market Cap
31.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2023-10-02
Address
5858 HORTON STREET, SUITE 370
EMERYVILLE, CA 94608
Phone: (510) 318-9098
EMERYVILLE, CA 94608
Phone: (510) 318-9098
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?94
Piotroski F-Score?0/9Weak
Altman Z-Score?-27.08Distress
Confidence?36%Very Low
Short InterestLow
Short % of Float?0.59%Low
Short Interest?89.1K
Days to Cover?2.5
Free Float15.1M
Avg Daily Volume36.4K
Settlement Date2026-06-30
Financial Health
Current Ratio?0.24Weak
Quick Ratio?0.24Weak
Cash Ratio?0.22Low
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-6.04CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?251.4%STRONG▾
Peers50
S&P97
ROA?-362.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$29.9M
Fundamentals ratios updated end of day